Warning: The NCBI web site requires JavaScript to function. more...
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.
Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW.
Harm Reduct J. 2004 Nov 9;1(1):9.
Related citations
Rationale for evaluating North America's first medically supervised safer-injecting facility.
Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW.
Lancet Infect Dis. 2004 May;4(5):301-6.
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Wood E, Tyndall MW, Montaner JS, Kerr T.
CMAJ. 2006 Nov 21;175(11):1399-404.
Do supervised injecting facilities attract higher-risk injection drug users?
Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.
Am J Prev Med. 2005 Aug;29(2):126-30.
The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
Wood E, Kerr T, Tyndall MW, Montaner JS.
Int J Drug Policy. 2008 Jun;19(3):220-5.
The role of safer injection facilities in the response to HIV/AIDS among injection drug users.
Kerr T, Kimber J, Debeck K, Wood E.
Curr HIV/AIDS Rep. 2007 Dec;4(4):158-64. Review.
Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.
Int J Drug Policy. 2008 Jun;19(3):183-8. Epub 2008 Mar 26.
A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T, Small W, Moore D, Wood E.
Int J Drug Policy. 2007 Jan;18(1):37-45. Epub 2007 Jan 16.
Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.
Public Health. 2005 Dec;119(12):1111-5. Epub 2005 Oct 7.
The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
Fast D, Small W, Wood E, Kerr T.
Harm Reduct J. 2008 Oct 29;5:32.
Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.
Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.
Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW.
CMAJ. 2004 Sep 28;171(7):731-4.
Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users.
Collins CL, Kerr T, Tyndall MW, Marsh DC, Kretz PS, Montaner JS, Wood E.
Can J Public Health. 2005 Sep-Oct;96(5):344-7.
Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T.
Addiction. 2007 Jun;102(6):916-9.
Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.
Collins CL, Kerr T, Kuyper LM, Li K, Tyndall MW, Marsh DC, Montaner JS, Wood E.
J Urban Health. 2005 Jun;82(2):276-84. Epub 2005 May 4.
Employment among users of a medically supervised safer injection facility.
Richardson L, Wood E, Zhang R, Montaner J, Tyndall M, Kerr T.
Am J Drug Alcohol Abuse. 2008;34(5):519-25.
Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
Wood E, Tyndall MW, Qui Z, Zhang R, Montaner JS, Kerr T.
Am J Public Health. 2006 May;96(5):770-3. Epub 2006 Mar 29.
My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
Green TC, Hankins CA, Palmer D, Boivin JF, Platt R.
Can J Public Health. 2004 Mar-Apr;95(2):110-4.
Changes in injecting practices associated with the use of a medically supervised safer injection facility.
Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T.
J Public Health (Oxf). 2007 Mar;29(1):35-9. Epub 2007 Jan 17.
HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment.
Tyndall MW, Wood E, Zhang R, Lai C, Montaner JS, Kerr T.
Harm Reduct J. 2006 Dec 18;3:36.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on